Moreover, we observed that the oncogenic role of IMP3 in prostate cancer was abrogated when SMURF1 expression was silenced in DU145 and LNCap cells, indicating that IMP3 promoted the progression of prostate cancer via increasing SMURF1 expression. Here, IMP3 is linked to prostate cancer.